Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life

Figure 3

Change in blood Gd concentrations of the 1st Gd-DTPA bolus versus of the 2nd Gd-DTPA bolus during 15 minute intravenous infusion of normal saline or respective bradykinin B2 agonist. (A) NS (N = 6), (B) BK (N = 8), (C) Lys-BK (N = 8), (D) Met-Lys-BK (N = 7), (E) Labradimil (N = 13). Error bars represent standard deviation.

Back to article page